← Open Payments lookup

MARINA BOTA: Open Payments

NPI 1164430831 · BLOOMINGTON, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,847 in 105 payments from 17 companies in 2025. Trend: 2023 $990 · 2024 $1,004 · 2025 $1,847

Food & beverage: $1,735Education: $111
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.26$384
Teva Pharmaceuticals USA, Inc.8$244
E.R. Squibb & Sons, L.L.C.14$240
Lundbeck LLC14$180
ABBVIE INC.12$179
Neurocrine BioSciences, Inc.6$123
Vanda Pharmaceuticals Inc.4$93
Axsome Therapeutics, Inc.2$63
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$62
Janssen Pharmaceuticals, Inc4$61

Products named: REXULTI, COBENFY, VRAYLAR, ABILIFY MAINTENA, INGREZZA, HETLIOZ, AUSTEDO XR, Auvelity.

Industry payments across IN — which companies pay providers there.